Xiaoguang Chen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Binding Protein

Squamous Cell Carcinoma

Dna Methylation

Top Venues

Cellular and molecular life sciences : CMLS

Basic & clinical pharmacology & toxicology

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Tingting Du, Xiaowen Hu, Zhenyan Hou, Weida Wang, Shen You, Mingjin Wang, Ming Ji, Nina Xue, Xiaoguang Chen
Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Tingting Du, Xiaowen Hu, Zhenyan Hou, Weida Wang, Shen You, Mingjin Wang, Ming Ji, Nina Xue, Xiaoguang Chen
Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Tingting Du, Xiaowen Hu, Zhenyan Hou, Weida Wang, Shen You, Mingjin Wang, Ming Ji, Nina Xue, Xiaoguang Chen
Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Zhaojun Li, Xingguang Zhang, Haijie Wu, Zhiling Ma, Xikun Liu, Jie Ma, Dongming Zhang, Li Sheng, Xiaoguang Chen, Yonghong Fu
Hydrangea paniculata coumarins attenuate experimental membranous nephritis by bidirectional interactions with the gut microbiota. Communications biology 6 (1) (2023)
Zhe Zhao, Fengying Gong, Lian Duan, Xiaorui Lv, Haijie Wu, Yan Tang, Huijuan Zhu, Xiaoguang Chen
Somatostatin receptor ligands suppressed proliferation and lipogenesis in 3T3-L1 preadipocytes. Basic & clinical pharmacology & toxicology 131 (3) (2022)